ALLP, Mixture Sciences immunotherapy deal

Alliance Pharmaceuticals (ALLP) granted to Mixture Sciences (San Diego, Calif.) exclusive rights to its epitope-based T cell immunotherapy (ETI) technology. ALLP will receive an upfront fee and is eli...